Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001662252-17-000119
Filing Date
2017-06-15
Accepted
2017-06-15 16:57:29
Documents
2
Period of Report
2016-12-20

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT form4a.html 4/A  
1 OWNERSHIP DOCUMENT form4a.xml 4/A 11246
2 EX-24 poa.htm EX-24 7945
  Complete submission text file 0001662252-17-000119.txt   20768
Mailing Address C/O ICAD, INC. 98 SPIT BROOK ROAD, SUITE 100 NASHUA NH 03062
Business Address
DEPTULA-HICKS DARLENE M (Reporting) CIK: 0001089409 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-37937 | Film No.: 17914039

Mailing Address 99 HAYDEN AVENUE, SUITE 230 LEXINGTON MA 02421
Business Address 99 HAYDEN AVENUE, SUITE 230 LEXINGTON MA 02421 781-778-7720
Xenetic Biosciences, Inc. (Issuer) CIK: 0001534525 (see all company filings)

EIN.: 452952962 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations